Tezepelumab Efficacy By SNOT-22 Score In Patients With Severe, Uncontrolled Asthma And Comorbid Nasal Polyps In NAVIGATOR

被引:0
|
作者
Jacobs, Joshua [1 ]
Hoyte, Flavia [2 ]
Spahn, Joseph [3 ]
Ambrose, Chris [4 ]
Martin, Nicole [5 ,6 ]
Vong, Sylvia [7 ]
Caveney, Scott [8 ]
Cook, Bill [4 ]
Colice, Gene [9 ]
机构
[1] Allergy & Asthma Clin Res, Walnut Creek, CA USA
[2] Natl Jewish Hlth, Div Allergy & Immunol, Denver, CO USA
[3] AstraZeneca, BioPharmaceut Med, Resp & Immunol, Wilmington, DE USA
[4] AstraZeneca, BioPharmaceut Med, Resp & Immunol, Gaithersburg, MD USA
[5] AstraZeneca, BioPharmaceut R&D, Resp & Immunol, Biometr,Late Stage Dev, Waltham, MA USA
[6] Cytel Inc, Waltham, MA USA
[7] AstraZeneca, BioPharmaceut R&D, Early Resp & Immunol, Translat Sci & Expt Med, Gaithersburg, MD USA
[8] Amgen Inc, R&D, Global Dev, Inflammat, Thousand Oaks, CA 91320 USA
[9] AstraZeneca, Biopharmaceut R&D, Resp & Immunol, Late Stage Dev, Gaithersburg, MD USA
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
052
引用
收藏
页码:AB17 / AB17
页数:1
相关论文
共 50 条
  • [1] Tezepelumab Efficacy by SNOT-22 Domain Scores in Patients With Severe, Uncontrolled Asthma and Comorbid Nasal Polyps in the Phase 3 Navigator Study
    Spahn, J. D.
    Jacobs, J. S.
    Hoyte, F.
    Ambrose, C. S.
    Martin, N.
    Vong, S.
    Caveney, S.
    Cook, B.
    Colice, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [2] Tezepelumab efficacy in patients with severe, uncontrolled asthma and comorbid nasal polyps in NAVIGATOR
    Welte, T.
    Menzies-Gow, A.
    Israel, E.
    Corren, J.
    Hunter, G.
    Cook, W.
    Colice, G.
    Lanos-Ackert, P. J.
    PNEUMOLOGIE, 2022, 76 : S12 - S12
  • [3] Tezepelumab Efficacy in Patients with Severe, Uncontrolled Asthma with Comorbid Nasal Polyps in NAVIGATOR 
    Laidlaw, Tanya M.
    Menzies-Gow, Andrew
    Caveney, Scott
    Han, Joseph K.
    Martin, Nicole
    Israel, Elliot
    Lee, Jason K.
    Llanos, Jean-Pierre
    Martin, Neil
    Megally, Ayman
    Parikh, Bhavini
    Vong, Sylvia
    Welte, Tobias
    Corren, Jonathan
    JOURNAL OF ASTHMA AND ALLERGY, 2023, 16 : 915 - 932
  • [4] Tezepelumab efficacy in patients with severe, uncontrolled asthma and comorbid nasal polyps in NAVIGATOR
    Menzies-Gow, Andrew
    Corren, Jonathan
    Israel, Elliot
    Welte, Tobias
    Ambrose, Christopher S.
    Cook, Bill
    Hunter, Gillian
    Llanos-Ackert, Jean-Pierre
    Colice, Gene
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [5] Tezepelumab Efficacy in Patients with Severe, Uncontrolled Asthma with Comorbid Nasal Polyps in NAVIGATOR (vol 16, pg 915, 2023)
    Laidlaw, Tm
    Menzies-Gow, A.
    Caveney, S.
    JOURNAL OF ASTHMA AND ALLERGY, 2023, 16 : 1053 - 1053
  • [6] Clinical Responses to Tezepelumab in Patients With Severe, Uncontrolled Asthma, and a History of Nasal Polyps From the NAVIGATOR Study
    Lugogo, N. L.
    Peters, A. T.
    Chupp, G. L.
    Wechsler, M. E.
    Caveney, S.
    Martin, N.
    Parikh, B.
    Ambrose, C. S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [7] TEZEPELUMAB EFFICACY ACCORDING TO BRONCHODILATOR REVERSIBILITY IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA IN NAVIGATOR
    Menzies-Gow, A.
    Bourdin, A.
    Korn, S.
    Cook, B.
    Ambrose, C.
    Ponnarambil, S.
    Hunter, G.
    Molfino, N.
    Colice, G.
    Llanos-Ackert, J.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 127 (05) : S37 - S37
  • [8] QUALITATIVE ASSESSMENT OF THE CONTENT VALIDITY OF THE SNOT-22 IN PATIENTS WITH NASAL POLYPS
    Hall, R.
    Trennery, C.
    Bradley, H.
    Gater, A.
    Sikirica, M., V
    Nelsen, L. M.
    Sousa, A.
    Chan, R.
    von Maltzahn, R.
    Evitt, L.
    VALUE IN HEALTH, 2019, 22 : S360 - S360
  • [9] EFFICACY OF TEZEPELUMAB IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA WITH COMORBID GASTROESOPHAGEAL REFLUX DISEASE: A POOLED ANALYSIS OF THE PATHWAY AND NAVIGATOR STUDIES
    Moore, Wendy C.
    Lugogo, Njira L.
    Chupp, Geoffrey L.
    Martin, Nicole
    Ambrose, Christopher
    Cook, William
    Ackert, Jean-Pierre Llanos
    CHEST, 2023, 164 (04) : 4A - 7A
  • [10] EFFICACY OF TEZEPELUMAB IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA GROUPED BY BASELINE BMI IN THE NAVIGATOR STUDY
    Chupp, Geoffrey
    Menzies-Gow, Andrew
    Ambrose, Christopher
    Cook, William
    Kmita, Kamil
    Lindsley, Andrew
    Llanos-Ackert, Jean-Pierre
    Colice, Gene
    Lugogo, Njira
    CHEST, 2021, 160 (04) : 37A - 40A